FOXO4 expression associates with glioblastoma development and FOXO4 expression inhibits cell malignant phenotypes in vitro and in vivo
Autor: | Lin Wang, Min Qi, Meng-Liang Zhou, Le-An Sun, Wang-Dui Zhaba, Wen-Hao Niu, Xiao-Chun Jiang, Mao-Xing Fei, Yan-Ling Han, Lan-rong Zheng |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Male Cell Down-Regulation Mice Nude Cell Cycle Proteins Biology Transfection 030226 pharmacology & pharmacy General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Nude mouse In vivo Glioma Cell Line Tumor medicine Animals Humans Viability assay General Pharmacology Toxicology and Pharmaceutics Mice Inbred BALB C Cell growth Brain Neoplasms Forkhead Transcription Factors General Medicine medicine.disease biology.organism_classification Xenograft Model Antitumor Assays nervous system diseases Gene Expression Regulation Neoplastic 030104 developmental biology medicine.anatomical_structure Phenotype Cell culture FOXO4 Cancer research Glioblastoma |
Zdroj: | Life sciences. 247 |
ISSN: | 1879-0631 |
Popis: | Background and aim Forkhead box protein O4 (FOXO4) is a transcription factor, and aberrant FOXO4 expression is associated with development of various human cancers. This study explored the role of FOXO4 in glioma in vitro and in vivo. Methods FOXO4 expression was first assessed in normal brain tissues, low-grade glioma, glioblastoma multiforme (GBM), normal human astrocytes (HA), and GBM cell lines, while manipulation of FOXO4 expression in glioma cell lines was assessed using qRT-PCR, Western blot, and cell viability CCK-8, Transwell, and a nude mouse subcutaneous xenograft assays. Key findings The data showed downregulated FOXO4 expression in GBM tissues and cell lines. FOXO4 overexpression induced by transfection with FOXO4 cDNA significantly inhibited GBM cell proliferation, migration, and invasion, but increased tumor cells to undergo apoptosis in vitro, while suppressed growth of GBM cell subcutaneous xenografts in nude mice. In conclusion, FOXO4 possesses an anti-cancer glioma activity, which could be a novel target for future control of GBM. |
Databáze: | OpenAIRE |
Externí odkaz: |